Amdocs Limited $DOX Shares Acquired by TD Asset Management Inc

TD Asset Management Inc lifted its position in Amdocs Limited (NASDAQ:DOXFree Report) by 24.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 162,587 shares of the technology company’s stock after purchasing an additional 32,391 shares during the period. TD Asset Management Inc’s holdings in Amdocs were worth $13,090,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Pzena Investment Management LLC lifted its stake in shares of Amdocs by 82.6% in the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock valued at $969,100,000 after purchasing an additional 5,443,766 shares during the period. LSV Asset Management lifted its stake in shares of Amdocs by 0.8% in the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock valued at $296,159,000 after purchasing an additional 29,829 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Amdocs by 1.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after purchasing an additional 54,676 shares during the period. Wellington Management Group LLP lifted its stake in shares of Amdocs by 3.0% in the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after purchasing an additional 91,900 shares during the period. Finally, Vanguard Group Inc. lifted its stake in shares of Amdocs by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after purchasing an additional 9,207 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Price Performance

Amdocs stock opened at $58.34 on Tuesday. Amdocs Limited has a 52-week low of $58.21 and a 52-week high of $95.41. The firm has a market capitalization of $6.30 billion, a price-to-earnings ratio of 11.67, a PEG ratio of 1.04 and a beta of 0.38. The company has a fifty day simple moving average of $63.82 and a 200-day simple moving average of $71.24. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOXGet Free Report) last released its earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business had revenue of $1.17 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the prior year, the firm earned $1.78 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. On average, equities analysts anticipate that Amdocs Limited will post 6.56 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.9%. Amdocs’s dividend payout ratio is currently 45.60%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Cfra cut shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Stifel Nicolaus reduced their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $86.67.

View Our Latest Analysis on DOX

Amdocs Company Profile

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.